Every day, nearly 1,000 Americans die from sudden cardiac arrest, a catastrophic event in which the heart suddenly stops functioning. The most common cause of sudden cardiac arrest is a sustained, super-fast heart rhythm called ventricular tachycardia, commonly called V-tach. Among heart specialists, this condition is known as VT.

Building on imaging methods long used on the heart, researchers have developed a new technology that can produce 3D maps showing the magnitude and distribution of uterine contractions in real time and across the entire surface of the uterus during labor.

Academic hospitals—those affiliated with major medical schools and dedicated not only to caring for patients but to research and training the next generation of physicians—make up just 5% of the 6,100 hospitals in the U.S., but they have a significant impact on the communities they serve. According to a study published in the Journal of the American Medical Association (JAMA), people who receive treatment at an academic hospital are up to 20% more likely to survive a complex illness than those treated at a non-academic hospital.

Men with prostate cancer that has metastasized, spreading to other parts of the body, now have a new treatment option available to them that, though not lifesaving, can offer a better quality of life. Approved by the Food and Drug Administration (FDA) in 2022, a drug, called lutetium Lu 177 vipivotide, or Pluvicto, may be used in patients for whom other available treatments did not work or became ineffective.

Imagine surgeons performing surgery with the assistance of augmented reality glasses. Or doing complex, minimally invasive procedures through an incision smaller than your fingernail. These aren’t some-day scenarios; they represent the latest advancements in spine surgeries, making these procedures more precise while causing less damage to surrounding healthy muscle and tissue.